Navigation Links
Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
Date:12/22/2010

Delcath Systems, Inc. is a development stage, specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi–arm Phase II trial to treat other liver cancers. The Company has not yet received FDA or any foreign regulatory approval for commercial sale of its system. For more information, please visit the Company's website at www.delcath.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward–looking statements made by the Company or on its behalf. This news release contains forward–looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, acceptance of the Company's NDA by the FDA, FDA's acceptance of the Company's request for and granting of priority review to the Company's NDA, approval of the Company's NDA by the FDA of the chemosaturation system for the treatment of metastatic melanoma, adoption, use and resulting sales, if any, of the chemosaturation system in the United States, the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, actions by the FDA or other regulatory agencies, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the co
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Nektar Therapeutics (Nasdaq: ... a human abuse liability (HAL) study for NKTR-181, ... entry into the brain.  This slow rate of entry is ... abuse of and addiction to current opioid analgesics. 1 ... was rated similar to placebo in "drug liking" and "feeling ...
(Date:6/19/2013)... /PRNewswire-iReach/ -- Today leading web researchers Change Sciences Group ... web sites for usability, engagement, and conversion. The rankings ... which compares how people experience sites with competitors and ... The top three performers are easier to use, more ... performers have usability problems, lack aspects of design that ...
(Date:6/19/2013)... , June 19, 2013 Today MedeAnalytics, ... introduced the next-generation of its Employer Group ... health plans to provide their employer groups an ... factors, medical and prescription drug claims, network utilization, ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group ...
Breaking Medicine Technology:Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2
... BATESVILLE, Ind., Nov. 19, 2010 Hill-Rom Holdings, Inc., ... to a management discussion at the 22nd Annual Piper ... Tuesday, November 30, 2010, at 12 p.m. EST. ... discussion via the internet link at http://ir.hill-rom.com/events.cfm ...
... the European Union poised to regulate probiotics, and with ... Americans need to know what they,re buying, and how these ... not these types of regulations in the U.S. As European ... U.S. consumers are still faced with a confusing array of ...
Cached Medicine Technology:As Europe Regulates Probiotics, Americans Need to Know What They're Buying 2As Europe Regulates Probiotics, Americans Need to Know What They're Buying 3
(Date:6/20/2013)... TX (PRWEB) June 20, 2013 ... maintained a wide range of outpatient and inpatient mental ... issues, including those who are children. As a facility ... explains that it is critical to diagnose mental health ... However, according to a recent article from ...
(Date:6/20/2013)... 2013 During a June 13 panel ... the Maryland Health Benefit Exchange confirmed the existence of ... in the industry consider,” writes panel moderator Steve Davis ... mythical as unicorns and leprechauns.” , “We are the ... Data Services Hub live,” Rebecca Pearce told attendees at ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Certified Nursing ... needing care in their home, and in nursing homes, ... long ago there was no formal job description or ... Week, from June 13 - 20th, 2013, recognizes certified ... during Career Nurse Assistant Week and recognizes the founding ...
(Date:6/20/2013)... 2013 Pedata RV Center , the ... campers that improperly handled food can cause bacterial illness that ... has arrived, many RV campers are enjoying the pleasures of ... eating outdoors at the campground or dining at a patio ... should be avoided at all costs. , While dangerous bacteria ...
(Date:6/20/2013)... Footwear etc. is pleased to announce the ... has received many new styles and colors for the spring. ... never before introduced in the U.S. The relaunch is expected ... MBT customers. , MBT shoes feature a unique rocker sole ... sole also provides outstanding shock absorption, and helps produce improved ...
Breaking Medicine News(10 mins):Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 2Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Career Nurse Assistant Week Celebrated with T-shirts Awarded Daily from Caregiverlist 2Health News:Career Nurse Assistant Week Celebrated with T-shirts Awarded Daily from Caregiverlist 3Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 3Health News:Footwear etc. Announces New MBT Shoes for Spring/Summer 2
... mind, not just the body , MONDAY, March 8 (HealthDay ... the mind function better, a new study suggests. , "It ... function," said Patrick Smith, an intern in clinical neuropsychology and ... online in the March 8 issue of Hypertension . ...
... ... ... ... ...
... ... ... ... ...
... Fla. Postmenopausal women, including those over 70 years ... breast have higher cancer detection rates when the other breast ... say researchers at the Mayo Clinic campus in Florida. ... cancer in the undiagnosed breast that had not been found ...
... ... significant medical bills benefit from working with a medical billing advocate who ... with medical care providers. Industry experts estimate that as many as ... denials by insurance plans. Because unpaid medical bills are a leading ...
... , ... ... ... ...
Cached Medicine News:Health News:Diet, Exercise Can Improve Thinking 2Health News:Diet, Exercise Can Improve Thinking 3Health News:Idaho Senate Set to Bring Home Divisiveness of Health Care Fight 2Health News:Idaho Senate Set to Bring Home Divisiveness of Health Care Fight 3Health News:Idaho Senate Set to Bring Home Divisiveness of Health Care Fight 4Health News:Sold Out! The UPMC Health Plan Pittsburgh Half Marathon and FedEx Ground Pittsburgh Marathon Relay Are Closed 2Health News:Sold Out! The UPMC Health Plan Pittsburgh Half Marathon and FedEx Ground Pittsburgh Marathon Relay Are Closed 3Health News:Sold Out! The UPMC Health Plan Pittsburgh Half Marathon and FedEx Ground Pittsburgh Marathon Relay Are Closed 4Health News:MRI finds tumors in second breast of women diagnosed with cancer in one breast, Mayo researchers say 2Health News:MRI finds tumors in second breast of women diagnosed with cancer in one breast, Mayo researchers say 3Health News:AttackMedicalBills.com Fights Medical Bill And Health Insurance Processing Errors For Consumers 2Health News:AttackMedicalBills.com Fights Medical Bill And Health Insurance Processing Errors For Consumers 3Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 2Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 3Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 4Health News:Want to Live a Healthier Lifestyle? Now There's an App for That, Too! 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: